IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · IEX Real-Time Price · USD
480.60
+4.78 (1.00%)
At close: May 3, 2024, 4:00 PM
485.47
+4.87 (1.01%)
After-hours: May 3, 2024, 4:42 PM EDT
IDEXX Laboratories Revenue
IDEXX Laboratories had revenue of $3.72B in the twelve months ending March 31, 2024, with 8.57% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $964.10M with 7.10% year-over-year growth. In the year 2023, IDEXX Laboratories had annual revenue of $3.66B with 8.72% growth.
Revenue (ttm)
$3.72B
Revenue Growth
+8.57%
P/S Ratio
10.72
Revenue / Employee
$338,623
Employees
11,000
Market Cap
39.93B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.66B | 293.63M | 8.72% |
Dec 31, 2022 | 3.37B | 151.96M | 4.73% |
Dec 31, 2021 | 3.22B | 508.71M | 18.79% |
Dec 31, 2020 | 2.71B | 299.75M | 12.45% |
Dec 31, 2019 | 2.41B | 193.67M | 8.75% |
Dec 31, 2018 | 2.21B | 244.18M | 12.40% |
Dec 31, 2017 | 1.97B | 193.64M | 10.91% |
Dec 31, 2016 | 1.78B | 173.53M | 10.83% |
Dec 31, 2015 | 1.60B | 116.09M | 7.81% |
Dec 31, 2014 | 1.49B | 108.75M | 7.90% |
Dec 31, 2013 | 1.38B | 83.72M | 6.47% |
Dec 31, 2012 | 1.29B | 74.65M | 6.13% |
Dec 31, 2011 | 1.22B | 115.30M | 10.45% |
Dec 31, 2010 | 1.10B | 71.76M | 6.96% |
Dec 31, 2009 | 1.03B | 7.60M | 0.74% |
Dec 31, 2008 | 1.02B | 101.48M | 11.00% |
Dec 31, 2007 | 922.56M | 183.44M | 24.82% |
Dec 31, 2006 | 739.12M | 101.02M | 15.83% |
Dec 31, 2005 | 638.10M | 88.91M | 16.19% |
Dec 31, 2004 | 549.18M | 73.19M | 15.38% |
Dec 31, 2003 | 475.99M | 63.32M | 15.34% |
Dec 31, 2002 | 412.67M | 26.59M | 6.89% |
Dec 31, 2001 | 386.08M | 18.65M | 5.08% |
Dec 31, 2000 | 367.43M | 9.06M | 2.53% |
Dec 31, 1999 | 358.37M | 36.66M | 11.39% |
Dec 31, 1998 | 321.71M | 58.74M | 22.34% |
Dec 31, 1997 | 262.97M | -4.71M | -1.76% |
Dec 31, 1996 | 267.68M | 79.08M | 41.93% |
Dec 31, 1995 | 188.60M | 62.24M | 49.25% |
Dec 31, 1994 | 126.36M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cencora | 271.58B |
Centene | 155.52B |
Humana | 109.24B |
Takeda Pharmaceutical | 29.40B |
IQVIA Holdings | 14.98B |
Haleon | 14.31B |
Alcon | 9.46B |
Moderna | 6.85B |
IDXX News
- 2 days ago - IDEXX Labs cuts 2024 revenue forecast on lagging vet visits, strong dollar - Reuters
- 2 days ago - IDEXX Laboratories Announces First Quarter Results - Business Wire
- 4 weeks ago - IDEXX Laboratories to Release 2024 First Quarter Financial Results - Business Wire
- 2 months ago - IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences - Business Wire
- 2 months ago - IDEXX Launches Vello™, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect - PRNewsWire
- 3 months ago - IDEXX Laboratories sees 2024 revenue above estimates - Reuters
- 3 months ago - IDEXX Announces Fourth Quarter and Full Year Results - Business Wire
- 3 months ago - IDEXX Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results - Business Wire